Expectant management of tubal pregnancies with human chorionic gonadotropin up to 2000 mIU/mL

Objective To describe outcomes of expectant management (EM) versus methotrexate (MTX) treatment in tubal pregnancies with pretreatment human chorionic gonadotropin (hCG) less than 2000 mIU/mL. Methods This retrospective cohort from two tertiary hospitals included women with confirmed tubal pregnanci...

Full description

Saved in:
Bibliographic Details
Published in:International journal of gynecology and obstetrics 2024-03, Vol.164 (3), p.1094-1100
Main Authors: Kugelman, Nir, Cohen, Bracha, Yossef, Fayrooz, Margieh, Nadine, Regev, Noam, Shani, Uria, Bart, Yossi
Format: Article
Language:English
Subjects:
expectant management
human chorionic gonadotropin levels
methotrexate
surgery
tubal pregnancy
tubal rupture
Citations: Items that this one cites
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Objective To describe outcomes of expectant management (EM) versus methotrexate (MTX) treatment in tubal pregnancies with pretreatment human chorionic gonadotropin (hCG) less than 2000 mIU/mL. Methods This retrospective cohort from two tertiary hospitals included women with confirmed tubal pregnancies and pretreatment hCG
ISSN:0020-7292
1879-3479
DOI:10.1002/ijgo.15162